Sunday, February 27, 2022 11:22:00 AM
rosequartz,
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168022673
This is a link to a "profile" on top. You can also get to the linked page here https://www.blockdata.tech/
without the profile.
rosequartz,
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168022907
"As far as the Weixen link. Weixin is china's wechat"
Is "Weixen" the social media site that stervc refers to here?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167174732
"it is easy to connect the dots that the social media site out there being used by Shanghai Yicheng Culture"
Much about Pang bo Group "egoc" comes from Weixen and twitter.
stervc , from EggMann123
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166323628
"A slide at a presentation at one of the EGOC events shows some of that structure. "
http://www.shishanggongzhu.com/uploads/allimg/210607/37-21060GK550441.jpg
http://www.shishanggongzhu.com I don't see the flow chart on "shishanggongzhu.com"
sterv, from lovetoseegreen
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168005914
"I love the fact they decided to WITHDRAW the application and move on with the ticker EGOC in order to move on with their plans."
sterv,
Can you elaborate more on "the plan"?
sterv,
https://microcapdaily.com/custodianship-spac-the-rise-of-energy-1-corp-otcmkts-egoc/
"On May 15, 2021, Shanghai Yicheng Culture, a subsidiary of Pangbo Group"
Can you verify this from any other source?
From the "Pangbo Group" website for example?
https://zgpangbo.com/a/about/
Pangbo Group was founded in 2016 and its headquarters are located in Hainan. In 2017, branches were set up in Beijing, Hainan, Shanghai, Guangzhou and Shandong, and the company is committed to building a domestic innovative high-end health technology platform, with industrialization as the core, developing a national health industry chain integrating innovative medical treatment, ecological construction, health management, film and television media. In 2019, at the invitation of Heze Municipal Government, Pangbo Group officially settled in Heze, and signed a long-term strategic cooperation agreement (joint research and development) with Heze Zhu Pharmaceutical in the same year. Pangbo Group is committed to building a big health industry chain, since its inception has always adhered to the principle of people-oriented, integrity management, gathering industry elites, the foreign advanced information technology, management methods and enterprise experience and the specific reality of domestic enterprises combined, to provide enterprises with a full range of solutions, to help enterprises improve management level and production capacity, so that enterprises in the fierce market competition to always maintain competitiveness, to achieve rapid and stable development of enterprises. The group company has more than 500 employees nationwide, with more than 100 personnel with various professional and economic and technical titles, including 60 people with middle and senior titles, 150 graduates of double-first-class universities, 1 executive of the world's top 500 enterprises, and 8 senior executives of large domestic listed companies. It has developed more than 200 large-scale medical devices, and in 2019, it was rated as "2019 New Venture" by Shenzhen Cultural Investment Office.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168022673
This is a link to a "profile" on top. You can also get to the linked page here https://www.blockdata.tech/
without the profile.
rosequartz,
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168022907
"As far as the Weixen link. Weixin is china's wechat"
Is "Weixen" the social media site that stervc refers to here?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167174732
"it is easy to connect the dots that the social media site out there being used by Shanghai Yicheng Culture"
Much about Pang bo Group "egoc" comes from Weixen and twitter.
stervc , from EggMann123
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166323628
"A slide at a presentation at one of the EGOC events shows some of that structure. "
http://www.shishanggongzhu.com/uploads/allimg/210607/37-21060GK550441.jpg
http://www.shishanggongzhu.com I don't see the flow chart on "shishanggongzhu.com"
sterv, from lovetoseegreen
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168005914
"I love the fact they decided to WITHDRAW the application and move on with the ticker EGOC in order to move on with their plans."
sterv,
Can you elaborate more on "the plan"?
sterv,
https://microcapdaily.com/custodianship-spac-the-rise-of-energy-1-corp-otcmkts-egoc/
"On May 15, 2021, Shanghai Yicheng Culture, a subsidiary of Pangbo Group"
Can you verify this from any other source?
From the "Pangbo Group" website for example?
https://zgpangbo.com/a/about/
Pangbo Group was founded in 2016 and its headquarters are located in Hainan. In 2017, branches were set up in Beijing, Hainan, Shanghai, Guangzhou and Shandong, and the company is committed to building a domestic innovative high-end health technology platform, with industrialization as the core, developing a national health industry chain integrating innovative medical treatment, ecological construction, health management, film and television media. In 2019, at the invitation of Heze Municipal Government, Pangbo Group officially settled in Heze, and signed a long-term strategic cooperation agreement (joint research and development) with Heze Zhu Pharmaceutical in the same year. Pangbo Group is committed to building a big health industry chain, since its inception has always adhered to the principle of people-oriented, integrity management, gathering industry elites, the foreign advanced information technology, management methods and enterprise experience and the specific reality of domestic enterprises combined, to provide enterprises with a full range of solutions, to help enterprises improve management level and production capacity, so that enterprises in the fierce market competition to always maintain competitiveness, to achieve rapid and stable development of enterprises. The group company has more than 500 employees nationwide, with more than 100 personnel with various professional and economic and technical titles, including 60 people with middle and senior titles, 150 graduates of double-first-class universities, 1 executive of the world's top 500 enterprises, and 8 senior executives of large domestic listed companies. It has developed more than 200 large-scale medical devices, and in 2019, it was rated as "2019 New Venture" by Shenzhen Cultural Investment Office.
